Classical and non‐classical metabolic transformation of vitamin D in dermal fibroblasts
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Until recently, it was widely believed that vitamin D3 (D3) was solely activated through the sequential hydroxylations by CYP27A1 or CYP2R1 at C25, and by CYP27B1 at C1 1, 2: [D3→25(OH)D3→1,25(OH)2D3]. This dogma has recently been broken by the discovery that CYP11A1 hydroxylates D3 producing 20-hydroxyvitamin D3 (20(OH)D3, which can undergo further sequential hydroxylations of the side chain without its cleavage (3-6s2): [D3→20(OH)D3→(OH)nD3]. CYP11A1 can also hydroxylate D3 at C22 to produce 22(OH)D3. Further hydroxylation of 22(OH)D3 or 20(OH)D3 by CYP11A1 produces 20,22(OH)2D3 and 20,23(OH)2D3 6: D3 → 20(OH)D3 + 22(OH)D3 → 20,23(OH)2D3 + 20,22(OH)2D3. The main products of this pathway are biologically active and can be further hydroxylated by CYP27B1 [reviewed in 7]. Furthermore, ex-vivo and ex-utero incubations of D3 with fragments of adrenal glands and human placenta, respectively, demonstrate that these CYP11A1-catalysed pathways of D3 metabolism occur in steroidogenic tissues with 20(OH)D3 being the major metabolite 8. CYP11A1-dependent metabolism of D3 has also been detected in epithelial cells such as epidermal keratinocytes 8 and colonic Caco-2 cells 7 which have a relatively low expression of this enzyme, and 20(OH)D3 has been detected in the human epidermis 9. However, it is unknown whether similar metabolism can occur in cells of mesenchymal origin such as dermal fibroblasts. As human dermal fibroblasts do express CYP11A1 10, we investigated whether they can transform vitamin D3 into novel CYP11A1-dependent hydroxyderivatives with possible 1α-hydroxylation of the major product, 20(OH)D3. The detailed description is provided in the Supplemental file. Briefly, human dermal fibroblasts from the foreskin of African American donors, passage #2, at a concentration of 3 × 106 cells/ml, were incubated in the presence of 0, 50 or 500 μm D3 at 37°C for 18 h and the suspension then extracted and processed as described previously 8. The resulting extracts were directly analysed by liquid chromatography–mass spectrometry (LC-MS) using a Xevo™ G2-S qTOF tandem mass spectrometer and ESI source with separations carried on a Waters Atlantis dC18 column (100 × 4.6 mm, 5 μm particle size) using a methanol in water gradient (Fig. 1). To further confirm the identity of products, extracts were initially separated on long a C18 columns (250 × 4.6 mm, 5 μm particle size) and purified fractions with retention times corresponding to those of appropriate mono- or di-hydroxyvitamin D3 standards were further analysed on a Waters Acquity™ Ultra Performance Liquid Chromatography (UPLC) system (Milford, MA, USA) equipped with a Waters Xevo™ G2-S qTOF MS and an ESI source (see Supporting information). Figure 1 shows dose-dependent transformation of D3 to mono- and di-hydroxyvitamin D3 metabolites for extracts directly analysed by LC-MS and monitored from the extracted mass at m/z = 383.3 [M+H-H2O]+ for mono-hydroxyvitamin D3 and m/z = 399.3 [M+H-H2O]+ for di-hydroxyvitamin D3. Species with RT corresponding to 25(OH)D3, 20(OH)D3, 1,25(OH)2D3, as well as for both 20,22(OH)2D3 and 20,23(OH)2D3 (20,22/23(OH)2D3) which did not separate under the HPLC conditions used, were detectable at 50 μm substrate and were dramatically higher with 500 μm D3 (Fig. 1a–f). The signal for 22(OH)D3 was buried in the descending shoulder of the peak at RT = 11.6 min (Fig. 1b,c), while that for 1,20(OH)2D3 was in the peak preceding 1,25(OH)2D3 (Fig. 1e,f). Therefore, to confirm that these additional expected products were present, and to further confirm the identity of the other major products, species with RT corresponding to 25(OH)D3, 20(OH)D3 22(OH)D3, 1,25(OH)2D3, 1,20(OH)2D3, 20,22(OH)2D3 and 20,23(OH)2D3 were separated and collected using a 250 mm C18 columns with an acetonitrile in water gradient. The individual fractions were then analysed by UPLC-qTOF MS using extracted masses as listed in Fig. 2. These data clearly show the production of the expected mono- and di-hydroxyvitamin D3 metabolites with detectable masses at [M+H]+ and [M+H-H2O]+ for the corresponding D3 derivatives (inserts in Fig. 2). In this study, we show for the first time that human dermal fibroblasts can transform D3, not only to 25(OH)D3 and 1,25(OH)2D3 (classical metabolites), but also to the newly discovered CYP11A1-dependent hydroxyderivatives of vitamin D3 including 20(OH)D3, 22(OH)D3, 20,22(OH)2D3, 20,23(OH)2D3 and 1,20(OH)2D3. These novel metabolic transformations are consistent with our previous detection of CYP11A1 enzyme in human dermal fibroblasts 10. Of note, there are similar levels of production of 1,25(OH)2D3 vs 20,22/23(OH)2D3 but higher production of 20(OH)D3 vs. 25(OH)D3 (Fig 1) which is consistent with greater metabolism of D3 by CYP11A1 than by the classical pathway [D3→25(OH)D3→1,25(OH)2D3] in tissues or cells expressing CYP11A1 6, 8. These findings allow to propose a novel scheme of vitamin D3 hydroxylations in dermal fibroblasts that includes both gene
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitamin D: a millenium perspective
Holick, M. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10338 · Cited by 1,319
Novel activities of CYP11A1 and their potential physiological significance
Slominski, A. T., Li, W., Kim, T.-K., Semak, I., Wang, J., Zjawiony, J. K., & Tuckey, R. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.010 · Cited by 292
Self-citationSlominski, A. T., Kim, T., Shehabi, H. Z., Semak, I., Tang, E. K. Y., Nguyen, M. N., Benson, H. A. E., Korik, E., Janjetovic, Z., Chen, J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-208975 · Cited by 266
Self-citationSlominski, A., Zjawiony, J., Wortsman, J., Semak, I., Stewart, J., Pisarchik, A., Sweatman, T., Marcos, J., Dunbar, C., & C. Tuckey, R. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04356.x · Cited by 243
Self-citationSlominski, A. T., Kim, T.-K., Li, W., Yi, A.-K., Postlethwaite, A., & Tuckey, R. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.012 · Cited by 170
Self-citationGuryev, O., Carvalho, R. A., Usanov, S., Gilep, A., & Estabrook, R. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336107100 · Cited by 170
The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism
Slominski, A., Semak, I., Zjawiony, J., Wortsman, J., Li, W., Szczesniewski, A., & Tuckey, R. C. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04819.x · Cited by 155
Self-citationPathways and products for the metabolism of vitamin D3 by cytochrome P450scc
Tuckey, R. C., Li, W., Zjawiony, J. K., Zmijewski, M. A., Nguyen, M. N., Sweatman, T., Miller, D., & Slominski, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06406.x · Cited by 118
Self-citation
Cited by
The serum vitamin D metabolome: what we know and what is still to discover
Tuckey, R. C., Cheng, C. Y. S., & Slominski, A. T. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.09.003 · Cited by 245
Self-citationSlominski, A. T., Kim, T.-K., Hobrath, J. V., Oak, A. S. W., Tang, E. K. Y., Tieu, E. W., Li, W., Tuckey, R. C., & Jetten, A. M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.024 · Cited by 143
“Production of 20(OH)D3, 22 (OH)D3, 20,23(OH)2D3, 20,22(OH)2D3, 1,20(OH)2D3 also occurs in human dermal fibroblasts incubated with D3 substrate [71].”
BackgroundSelf-citationSlominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Self-citationEnvironmental Air Pollutants Affecting Skin Functions with Systemic Implications
Bocheva, G., Slominski, R. M., & Slominski, A. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310502 · Cited by 94
Self-citationSlominski, A. T., Kim, T.-K., Hobrath, J. V., Janjetovic, Z., Oak, A. S. W., Postlethwaite, A., Lin, Z., Li, W., Takeda, Y., Jetten, A. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10202-7 · Cited by 82
Self-citationNoncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models
Skobowiat, C., Oak, A. S. W., Kim, T.-K., Yang, C. H., Pfeffer, L. M., Tuckey, R. C., & Slominski, A. T. (2017) · Oncotarget · doi:10.18632/oncotarget.14193 · Cited by 44
Self-citation
Metadata
- Authors
- Slominski, A. T., Kim, T., Li, W., & Tuckey, R. C.
- Venue
- Experimental Dermatology
- Publisher
- Wiley
- Published
- 2016-01-15
- Volume
- 25
- Issue
- 3
- Pages
- 231-232
- ISSN
- 0906-6705 (ISSN-L)
- 1600-0625
- OpenAlex
- W2176208129
- Cited by
- 62
- References
- 8
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.